
News and Publications
NEWS
02/09/2022
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Funding to support progression of lead progranulin enhancer program into IND-enabling studies Small molecule platform…
12/06/2021
Arkuda Therapeutics Awarded Michael J. Fox Foundation Grant to Accelerate Development of Compounds for Parkinson’s Disease
Watertown, MA – December 6, 2021 – Arkuda Therapeutics, a biotechnology company applying new insights at the inte…
03/24/2021
Arkuda Therapeutics to Participate in Stifel’s 3rd Annual CNS Day
Watertown, MA – March 25, 2021 – Arkuda Therapeutics, a biotechnology company applying new insights into lysosoma…
PUBLICATIONS
10/07/2021
DISCOVERY OF SMALL MOLECULES FOR THE TREATMENT OF PD-GBA
Natasha Khatri, Mary K. Wozniak, Jerusha K. Brendel, Anna-Maria Alves, Christopher J. Holler, James C. Lanter, Duane …
04/08/2020
DISCOVERY OF NOVEL SMALL MOLECULES FOR THE TREATMENT OF FTD-GRN
Christopher J. Holler, Angela Chen, Natasha Khatri, James C. Lanter, Ricardo L. Sanz, Jerusha K. Brendel, Mary Woznia…
MEDIA CONTACT
Lissette Steele
Verge Scientific Communications
lsteele@vergescientific.com
202.930.4762
